Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Restructuring Costs (2022 - 2025)

Marimed (MRMD) has disclosed Restructuring Costs for 4 consecutive years, with $90000.0 as the latest value for Q4 2025.

  • Quarterly Restructuring Costs fell 38.36% to $90000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $486000.0 through Dec 2025, down 48.9% year-over-year, with the annual reading at $486000.0 for FY2025, 48.9% down from the prior year.
  • Restructuring Costs for Q4 2025 was $90000.0 at Marimed, down from $145000.0 in the prior quarter.
  • The five-year high for Restructuring Costs was $754000.0 in Q2 2022, with the low at $32000.0 in Q3 2023.
  • Average Restructuring Costs over 4 years is $206200.0, with a median of $143000.0 recorded in 2022.
  • The sharpest move saw Restructuring Costs tumbled 77.62% in 2023, then skyrocketed 1059.38% in 2024.
  • Over 4 years, Restructuring Costs stood at $64000.0 in 2022, then decreased by 25.0% to $48000.0 in 2023, then soared by 204.17% to $146000.0 in 2024, then tumbled by 38.36% to $90000.0 in 2025.
  • According to Business Quant data, Restructuring Costs over the past three periods came in at $90000.0, $145000.0, and $139000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.